The recent American Association for the Liver Diseases (AASLD) guidelines recommend antiviral therapy when alanine aminotransferase (ALT) ≥ 2 upper limit of normal (ULN), moderate or severe inflammation or significant fibrosis and HBV-DNA elevation [6]. The gene discussed is GPT; the disease is liver disorder.